CapsoVision, Inc (CV) Market Cap & Valuation Ratios
CapsoVision, Inc (CV) has a market cap of $349.8M and a price-to-sales ratio of 25.2, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CVCapsoVision, IncFollow CV — free
—
Price chart with a free account
- Market cap
- 349.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 12 Nov, in 19 days
Peers
medical devices · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| CV | 0.3 | — | 24.5 | — | -8.0% | +11% | -217% | -737% |
| RCEL | 0.5 | — | 6.8 | — | -5.3% | +1.0% | -47% | -263% |
| MASS | 0.5 | — | 6.1 | — | 0.1% | +13% | -64% | -52% |
| CERS | 0.5 | — | 1.9 | — | -0.4% | +23% | -0.6% | -1% |
| NPCE | 0.4 | — | 4.6 | — | -2.6% | +12% | -15% | -27% |
| OFIX | 0.4 | — | 0.6 | 37.9 | -7.0% | +3% | -5% | -7% |
| VMD | 0.4 | 27.2 | 1.2 | 7.0 | 7.8% | +25% | 8% | 12% |
| QSI | 0.3 | — | 121.3 | — | — | -53% | — | -62% |
| CLPT | 0.3 | — | 7.1 | — | -11.2% | +26% | -73% | -160% |
| TMCI | 0.3 | — | 1.4 | — | -9.0% | -4% | -26% | -42% |
| LAB | 0.2 | — | — | — | — | -5% | -113% | -36% |
| Median of these 10 | 27.2 | 4.6 | 22.4 | -3.9% | +7% | -26% | -39% |
; EV/Sales 24.5 vs. 4.6.
Growth vs. price
each dot a company · hover or tap for valuesCapsoVision, Inc — questions
- What is CapsoVision, Inc's market cap?
- $349.8M.
- What is CapsoVision, Inc's price-to-sales ratio?
- 25.2.
Every figure on this page comes from CapsoVision, Inc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.